BioNTech SE (BNTX) Current Assets (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Current Assets data on file, last reported at $18.8 billion in Q4 2025.

• For the quarter ending Q4 2025, Current Assets fell 6.46% year-over-year to $18.8 billion; the trailing twelve-month figure through Dec 2025 stood at $18.8 billion (down 6.46% YoY), and the FY2025 full-year result was $18.2 billion, down 9.21% from the prior year.
• Current Assets grew to $18.8 billion in Q4 2025, from $18.5 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $22.4 billion in Q4 2022 to a low of $4.3 billion in Q1 2021.
• A 5-year average of $18.5 billion and a median of $20.0 billion in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets soared 1385.59% in 2021 and declined 17.21% in 2025, its largest moves.
• Tracing BNTX's Current Assets over 5 years: stood at $17.2 billion in 2021, then gained by 29.72% to $22.4 billion in 2022, then fell by 6.06% to $21.0 billion in 2023, then retreated by 4.36% to $20.1 billion in 2024, then dropped by 6.46% to $18.8 billion in 2025.
• Business Quant data shows BNTX's Current Assets at $18.8 billion in Q4 2025, $18.5 billion in Q3 2025, and $18.0 billion in Q2 2025.